Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,289 | $17,451 | $23,869 | $15,310 |
| - Cash | $174 | $265 | $117 | $82 |
| + Debt | $86 | $153 | $151 | $189 |
| Enterprise Value | $12,201 | $17,340 | $23,903 | $15,417 |
| Revenue | $638 | $1,280 | $951 | $939 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Gross Profit | $404 | $530 | $589 | $558 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| EBITDA | $211 | $654 | $276 | $246 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |
| Net Income | $123 | $377 | $153 | $25 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| % Growth | -67.2% | 146.2% | 510.3% | – |
| Operating Cash Flow | $142 | $549 | $233 | $273 |
| Capital Expenditures | -$30 | -$103 | -$40 | -$53 |
| Free Cash Flow | $112 | $446 | $193 | $220 |